Clinical trial
Study for the Treatment of Ulcerative Colitis With Adacolumn
NCT00102193 · Otsuka America Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00102193 |
|---|---|
| Title | Study for the Treatment of Ulcerative Colitis With Adacolumn |
| Official title | A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Ulcerative Colitis |
| Lead sponsor | Otsuka America Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Device |
| Interventions | Adacolumn Apheresis System |
| Enrollment | 168 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jan 25, 2005 |
| Last update posted | Sep 8, 2008 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: